Shares of BrainsWay Ltd. (BWAY) hit an all-time high of $16.99 yesterday, and that reflects a gain of nearly 79% year-to-date.
The company's flagship technology is Deep Transcranial Magnetic Stimulation or Deep TMS. The approved indications for Deep TMS include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction, with additional indications in various psychiatric, neurological, and addiction disorders being explored.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com